But it stands to reason that the drug companies ought to pay for the trials. Firstly, they are the ones who stand to win big if their drug actually works, therefore they are the ones who ought to take the risk. Secondly, the way insurers are structured financially is to reduce risk; whereas the financial structure of drug companies is to basically gamble the company on every new drug.